First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

RR MacGregor, JD Boyer, KE Ugen… - Journal of infectious …, 1998 - academic.oup.com
A DNA-based vaccine containing human immunodeficiency virus type 1 (HIV-1) env and rev
genes was tested for safety and host immune response in 15 asymptomatic HIV-infected …

[HTML][HTML] Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

P Tebas, SP Yang, JD Boyer, EL Reuschel… - …, 2021 - thelancet.com
Background A vaccine against SARS-CoV-2 is of high urgency. Here the safety and
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen …

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

ML Bagarazzi, J Yan, MP Morrow, X Shen… - Science translational …, 2012 - science.org
Despite the development of highly effective prophylactic vaccines against human
papillomavirus (HPV) serotypes 16 and 18, prevention of cervical dysplasia and cancer in …

Modulating the immune response to genetic immunization

AD Cohen, JD Boyer, DB Weiner - The FASEB journal, 1998 - Wiley Online Library
Genetic immunization, also known as DNA or polynucleotide immunization, is a novel
strategy for vaccine development in which plasmid DNA encoding either individual or a …

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination

JD Boyer, KE Ugen, B Wang, M Agadjanyan… - Nature medicine, 1997 - nature.com
Novel approaches for the generation of more effective vaccines for HIV-1 are of significant
importance. In this report we analyze the immunogenicity and efficacy of an HIV-1 DNA …

In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.

JJ Kim, V Ayyavoo, ML Bagarazzi… - … (Baltimore, Md.: 1950 …, 1997 - journals.aai.org
Recent studies support the importance of investigating a DNA vaccination approach for the
immunologic control of HIV-1. In this regard, it may be important to specifically engineer …

[HTML][HTML] The chimpanzee and other non-human-primate models in HIV-1 vaccine research

BM Nath, KE Schumann, JD Boyer - Trends in microbiology, 2000 - cell.com
Animal models are of great importance for the study of disease pathogenesis, particularly
non-human-primate models of infectious diseases. The role of non-human primates in HIV-1 …

Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions

L Maldonado, JE Teague, MP Morrow… - Science translational …, 2014 - science.org
About 25% of high-grade cervical intraepithelial neoplasias (CIN2/3) caused by human
papillomavirus serotype 16 (HPV16) undergo complete spontaneous regression. However …

CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.

JJ Kim, LK Nottingham, JI Sin, A Tsai… - The Journal of …, 1998 - Am Soc Clin Investig
The potential roles of CD8 (+) T-cell-induced chemokines in the expansion of immune
responses were examined using DNA immunogen constructs as model antigens. We …

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help

MA Kutzler, TM Robinson, MA Chattergoon… - The Journal of …, 2005 - journals.aai.org
DNA vaccines are a promising technology for the induction of Ag-specific immune
responses, and much recent attention has gone into improving their immune potency. In this …